Literature DB >> 14644116

Combined reporting of cancer control and functional results of radical prostatectomy.

Laurent Salomon1, Fabien Saint, Aristotelis G Anastasiadis, Philippe Sebe, Dominique Chopin, Clément-Claude Abbou.   

Abstract

INTRODUCTION: The results of radical prostatectomy (cancer control, continence and sexual potency) are currently presented separately, while the success of this surgery depends on a combination of good cancer control with maintenance of continence and erections. We propose a score to jointly evaluate and report cancer control and functional results.
METHODS: The results of 205 radical prostatectomies were studied at one year. Cancer control was evaluated by PSA. Continence and sexual potency were evaluated by a self-administered questionnaire. Each patient was attributed 0 or 4 points according to the presence of absence of biochemical progression (PSA>0.2 ng/ml), 0 or 2 points according to the presence or absence of urinary incontinence (use of pads) and 0 or 1 point according to the presence or absence of impotence (no erections). The sum of these points provided a score classifying the patient into 8 distinct categories, from 0 to 7, each corresponding to a specific status (from 0 (0+0+0): no cancer control-incontinence-impotence to 7 (4+2+1): cancer control-continence-sexual potency).
RESULTS: One year after the operation, 175 (85%) of patients had a PSA less than 0.2 ng/ml, 135 (65.8%) were continent and 64 (32.7%) reported erections. All patients with a score > or =4 had good cancer control, with no functional disorders for a score of 7 (4+2+1) (20%), no disorders of continence for a score of 6 (4+2+0) (31.5%), no disorders of erection for a score of 5 (4+0+1) (8.3%), or with incontinence and impotence for a score of 4 (4+0+0) (21.9%). All patients with a score <4 had a PSA>0.2 ng/ml, but with no functional disorders for a score of 3 (0+2+1) (2.4%), no incontinence for a score of 2 (0+2+0) (8.3%), and no impotence for a score of 1 (0+0+1) (1.9%). 1.9% of patients were incontinent, impotent and showed signs of biochemical progression (score 0=0+0+0).
CONCLUSION: This score allows analysis of the global (cancer control and functional) results of radical prostatectomy and would facilitate comparisons between various surgical techniques (type of approach, nerve-sparing techniques) and various centres.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14644116     DOI: 10.1016/j.eururo.2003.09.009

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  9 in total

1.  Variations in the quality of care at radical prostatectomy.

Authors:  Quoc-Dien Trinh; Jesse Sammon; Jay Jhaveri; Maxine Sun; Khurshid R Ghani; Jan Schmitges; Wooju Jeong; James O Peabody; Pierre I Karakiewicz; Mani Menon
Journal:  Ther Adv Urol       Date:  2012-04

2.  Laparoscopic versus robot-assisted bilateral nerve-sparing radical prostatectomy: comparison of pentafecta rates for a single surgeon.

Authors:  Anastasios D Asimakopoulos; Roberto Miano; Nicola Di Lorenzo; Enrico Spera; Giuseppe Vespasiani; Camille Mugnier
Journal:  Surg Endosc       Date:  2013-06-27       Impact factor: 4.584

3.  Evolution of health-related quality of life two to seven years after retropubic radical prostatectomy: evaluation by UCLA prostate cancer index.

Authors:  Aurélien Descazeaud; Marc Zerbib; Matthias D Hofer; Joël Chaskalovic; Bernard Debré; Michaël Peyromaure
Journal:  World J Urol       Date:  2005-09-01       Impact factor: 4.226

Review 4.  Inguinal hernia after radical retropubic prostatectomy: risk factors and prevention.

Authors:  Johan Stranne; Pär Lodding
Journal:  Nat Rev Urol       Date:  2011-04-05       Impact factor: 14.432

5.  Pilot trial of adjuvant paclitaxel plus androgen deprivation for patients with high-risk prostate cancer after radical prostatectomy: results on toxicity, side effects and quality-of-life.

Authors:  G Ploussard; B Paule; L Salomon; Y Allory; S Terry; D Vordos; A Hoznek; F Vacherot; C-C Abbou; S Culine; A de la Taille
Journal:  Prostate Cancer Prostatic Dis       Date:  2009-11-24       Impact factor: 5.554

6.  Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram.

Authors:  James A Eastham; Peter T Scardino; Michael W Kattan
Journal:  J Urol       Date:  2008-04-18       Impact factor: 7.450

Review 7.  Comparative effectiveness of robotic and open radical prostatectomy.

Authors:  Rodrigo Rodrigues Pessoa; Paul Maroni; Janet Kukreja; Simon P Kim
Journal:  Transl Androl Urol       Date:  2021-05

8.  Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma: A Proposal for Standardization of Quality Care Metrics.

Authors:  Frederik König; Nico C Grossmann; Francesco Soria; David D'Andrea; Tristan Juvet; Aaron Potretzke; Hooman Djaladat; Alireza Ghoreifi; Eiji Kikuchi; Nozomi Hayakawa; Andrea Mari; Zine-Eddine Khene; Kazutoshi Fujita; Jay D Raman; Alberto Breda; Matteo Fontana; John P Sfakianos; John L Pfail; Ekaterina Laukhtina; Pawel Rajwa; Maximilian Pallauf; Giovanni E Cacciamani; Thomas van Doeveren; Joost L Boormans; Alessandro Antonelli; Marcus Jamil; Firas Abdollah; Jeffrey Budzyn; Guillaume Ploussard; Axel Heidenreich; Siamak Daneshmand; Stephen A Boorjian; Morgan Rouprêt; Michael Rink; Shahrokh F Shariat; Benjamin Pradere
Journal:  Cancers (Basel)       Date:  2022-03-31       Impact factor: 6.639

9.  Effect of Reconstructive Techniques on Continence in Robot-Assisted Laparoscopic Prostatectomy: Novel Combination of Long Urethral Stump and Anterior Suspension Suture.

Authors:  Ibrahim Karabulut; Fatih Kursat Yilmazel; Ali Haydar Yilmaz; Erkan Cem Celik; Onur Ceylan; Fatih Ozkaya; Senol Adanur; Ozkan Polat
Journal:  Eurasian J Med       Date:  2020-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.